Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
François‐Clément Bidard(Inserm), Paul Cottu(Université Paris Sciences et Lettres), Charlotte Proudhon(Inserm), Fabien Reyal(Université Paris Sciences et Lettres), Denise M. Wolf, Eduardo Díaz‐Rubio(Hospital Clínico San Carlos), Patrice Viens(Centre National de la Recherche Scientifique), Florin‐Andrei Taran(University of Cologne), Randi R. Mathiesen(Oslo University Hospital), Daniele Generali(University of Trieste), Daisuke Takata(Gunma University Hospital), Marisa Maestro(Hospital Clínico San Carlos), H. Tokiniwa(Gunma University Hospital), Sara Y. Brucker(University Children's Hospital Tübingen), Carolyn Hall(The University of Texas MD Anderson Cancer Center), José Á. García-Sáenz(Hospital Clínico San Carlos), Andreas D. Hartkopf(University of Tübingen), Antonio Llombart‐Cussac(MedSIR (Spain)), José Vidal-Martínez(Hospital Arnau de Vilanova), Jeffrey B. Smerage(University of Michigan), Paul Blanche(Université de Bretagne Sud), Alessandra Meddis(Inserm), Maria Rosa Cappelletti(University of Trieste), Anthony Lucci(The University of Texas MD Anderson Cancer Center), Mandar Karhade(The University of Texas MD Anderson Cancer Center), Karsten E. Weber(German Breast group), Françoise Rothé(Université Libre de Bruxelles), Wendy Onstenk(Erasmus MC Cancer Institute), Stefan Sleijfer(Erasmus MC Cancer Institute), Olav Engebraaten(Oslo University Hospital), Elin Borgen(Oslo University Hospital), Jessica B. Bauldry(The University of Texas MD Anderson Cancer Center), Laura Muinelo‐Romay(Instituto de Investigación Sanitaria de Santiago), Rafael Gisbert‐Criado(Hospital Arnau de Vilanova), Stefan Michiels(Institut Gustave Roussy), Michail Ignatiadis(Université Libre de Bruxelles), Vicente Carañana(Hospital Arnau de Vilanova), Dominic Amara, Koenraad D’Hollander(International Drug Development Institute (Belgium)), Mark Jesus M. Magbanua(University of California, San Francisco), Laura J. Esserman(University of California, San Francisco), Sabine Riethdorf(Universität Hamburg), Justin Stebbing(Anglia Ruskin University), Noriyoshi Fujisawa(Kyoto University Hospital), Jaco Kraan(Erasmus MC Cancer Institute), Masakazu Toi(Mukogawa Women's University), Volkmar Müller(Universität Hamburg), Bjørn Naume(Norwegian Cancer Society), Rin Nagaoka(Gunma University Hospital), Jun Horiguchi(International University of Health and Welfare)
Cited by 282
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
|Journal of Clinical Oncology|2017|1.7k